Landaas & CO Acadia Pharmaceuticals Inc Transaction History

Landaas & CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$13.03 - $21.81 $1,954 - $3,271	-150 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$15.07 - $22.34 $2,260 - $3,351	150 New	150 $2,000
Q1 2018 May 14, 2018	SELL	$22.47 - $32.33 $3,370 - $4,849	-150 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$29.49 - $38.37 $4,423 - $5,755	150	150 $6,000

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.68B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Landaas & CO , based on Form 13F filings with the SEC.

Stay updated on Landaas & CO with notifications on news.